Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

Area of Science:

• Neuroscience
• Ophthalmology
• Medical Diagnostics

Background:

• Neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD) significantly impact individuals and society, often manifesting prodromal symptoms after middle age.
• Current diagnostic methods, including MRI, are valuable but can be costly, time-consuming, and inaccessible.
• Both AD and PD share common pathophysiological mechanisms affecting the brain and visual system, including the retina.

Purpose of the Study:

• To explore the link between Alzheimer's disease and Parkinson's disease and retinal degeneration.
• To highlight the potential of retinal analysis as a noninvasive, cost-effective method for early diagnosis of neurodegenerative diseases.

Main Methods:

• Review of existing literature on the shared pathophysiological mechanisms between AD, PD, and retinal changes.
• Analysis of how biomarkers like α-synuclein, neurofibrillary tangles, and amyloid β plaques manifest in both the brain and retina.
• Evaluation of ophthalmic examination as a diagnostic tool for early detection.

Main Results:

• Pathological hallmarks of AD and PD, such as α-synuclein deposition and amyloid plaques, are found in retinal cells.
• These retinal changes correlate with alterations in visual cortex and retinal function, mirroring brain pathology.
• Retinal neurodegeneration serves as a potential indicator for early-stage AD and PD.

Conclusions:

• Ophthalmic evaluation of retinal neurodegeneration offers a promising, accessible approach for early AD and PD diagnosis.
• This method can overcome the limitations associated with traditional neuroimaging techniques.
• Further research into retinal biomarkers could revolutionize the early detection of neurodegenerative diseases.